【Diamond BioFund】Announcement on Lifting Non-Compete Restrictions for Directors
Key facts
- 【Diamond BioFund】Announcement on Lifting Non-Compete Restrictions for Directors
- Diamond BioFund's shareholders' meeting on May 27, 115, approved the lifting of non-compete restrictions for Chairman Yang Pan-chyr, allowing him to hold concurrent positions.
- Source: PR Times
- Date: May 27, 2026
Direct answer
Diamond BioFund's shareholders' meeting on May 27, 115, approved the lifting of non-compete restrictions for Chairman Yang Pan-chyr, allowing him to hold concurrent positions.
- Citation
- 【Diamond BioFund】Announcement on Lifting Non-Compete Restrictions for Directors (May 27, 2026), PR Times
- Source
- PR Times
- Date
- May 27, 2026
Diamond BioFund's shareholders' meeting on May 27, 115, approved the lifting of non-compete restrictions for Chairman Yang Pan-chyr, allowing him to hold concurrent positions.
📋 Article Processing Timeline
- 📰 Published: May 27, 2026 at 09:00
- 🔍 Collected: May 28, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:53 (82h 53m after Collected)
1. Date of shareholders' meeting resolution: 115/05/27. 2. Name and title of director permitted to engage in competitive behavior: (1) Chairman: Representative of Oneness Biotech Co., Ltd.: Yang Pan-chyr. 3. Items of permitted competitive behavior: (1) Chairman: Representative of Oneness Biotech Co., Ltd.: Yang Pan-chyr. Permitted items: Director of Taishin Venture Capital Co., Ltd., Independent Director of Deep01 Co., Ltd., Director of Taiwan AI Development Foundation, Chairman of Taiwan Health Network Platform Co., Ltd. 4. Period of permission: 115/05/27~116/07/31. 5. Resolution status: The chairman ordered a vote. Total voting rights present: 722,689,752. Votes in favor: 718,031,431 (99.35%). The proposal was passed. 6. Engagement in Mainland China business: N/A. 7. Company name and position in Mainland China: N/A. 8. Address of Mainland China business: N/A. 9. Business items in Mainland China: N/A. 10. Impact on financial business: N/A. 11. Investment amount in Mainland China: N/A. 12. Other matters: None.
FAQ
Why is the non-compete clause lifted?
To allow the executive to hold concurrent positions and leverage their expertise.
What are the key facts in this article?
Diamond BioFund's shareholders' meeting on May 27, 115, approved the lifting of non-compete restrictions for Chairman Yang Pan-chyr, allowing him to hold concurrent positions.
What is the direct answer?
Diamond BioFund's shareholders' meeting on May 27, 115, approved the lifting of non-compete restrictions for Chairman Yang Pan-chyr, allowing him to hold concurrent positions.